Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema: The CONVERT II Trial

NCT06035120 is registered in ClinicalTrials.gov with Pulmonx Corporation as lead sponsor.

NCT NCT06035120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06035120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema: The CONVERT II Trial
Lead sponsor
Pulmonx Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
February 22, 2024
Completion date
March 31, 2028
Enrollment
200 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema or copd, emphysema, pulmonary